- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02631902
Diabetes em Movimento® - Community-based Lifestyle Intervention Program for Patients With Type 2 Diabetes
August 17, 2019 updated by: Romeu Duarte Carneiro Mendes, University of Trás-os-Montes and Alto Douro
Diabetes em Movimento® - Community-based Lifestyle Intervention Program for Patients With Type 2 Diabetes: Effects on Health and Well-being
Type 2 diabetes is a chronic disease that affects approximately 13% of Portuguese population and is associated with a high cardiovascular mortality by coronary artery disease and cerebrovascular disease and with a serious decline on well-being.
Lifestyle changes are widely recommended to the control of type 2 diabetes and its complications.
This study aims to analyse the effects of different community-based lifestyle programs (exercise or exercise plus dietary intervention) on health and well-being in patients with type 2 diabetes.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
90
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Vila Real, Portugal, 5000-801
- University of Trás-os-Montes e Alto Douro
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients with diagnosed type 2 diabetes at least for six months;
- Both genders;
- Aged between 50 and 80 years old;
- Non-smokers;
- Not engaged in supervised exercise;
- Community-dwelling;
- Medical recommendation for lifestyle intervention;
- Known medical history;
- Diabetes complications under medical control (poor metabolic control, diabetic foot, diabetic retinopathy, diabetic nephropathy and diabetic autonomic neuropathy;
- No cardiovascular, respiratory and musculoskeletal contraindications to exercise;
- No gait and balance problems;
- Not taking insulin or sulfonylureas for less than three months;
- Volunteer participation with signed informed consent.
Exclusion Criteria:
- Participation in another supervised exercise program during the study;
- Participation in another supervised dietary intervention during the study;
- Aggravation of a diabetes complication or another major health problem;
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Exercise
Community-based exercise program
|
Community-based exercise program with 3 weekly exercise sessions
|
|
Experimental: Exercise plus dietary intervention
Community-based exercise and dietary intervention program
|
Community-based exercise program with 3 weekly exercise sessions
Community-based dietary intervention program
|
|
No Intervention: Control
Habitual physical activity and habitual dietary pattern
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cardiovascular Risk
Time Frame: Baseline, 9 and 21 months
|
UKPDS Risk Engine
|
Baseline, 9 and 21 months
|
|
Health-Related Quality of Life
Time Frame: Baseline, 9 and 21 months
|
SF-36 Health Survey
|
Baseline, 9 and 21 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Food Literacy
Time Frame: Baseline, 9 and 21 months
|
General Nutrition Knowledge Questionnaire for Adults
|
Baseline, 9 and 21 months
|
|
Dietary Pattern
Time Frame: Baseline, 9 and 21 months
|
3-day Food Record
|
Baseline, 9 and 21 months
|
|
Physical Fitness
Time Frame: Baseline, 9 and 21 months
|
Physical Fitness Test Battery
|
Baseline, 9 and 21 months
|
|
Diabetic Foot Risk
Time Frame: Baseline, 9 and 21 months
|
International Working Group on the Diabetic Foot Risk Classification)
|
Baseline, 9 and 21 months
|
|
Exercise-Related Adverse Events
Time Frame: Baseline, 9 and 21 months
|
Number of acute injuries or adverse events during exercise sessions
|
Baseline, 9 and 21 months
|
|
Systolic Blood Pressure
Time Frame: Baseline, 9 and 21 months
|
mmHg
|
Baseline, 9 and 21 months
|
|
Diastolic Blood Pressure
Time Frame: Baseline, 9 and 21 months
|
mmHg
|
Baseline, 9 and 21 months
|
|
Glycemic Control
Time Frame: Baseline, 9 and 21 months
|
Glycated Hemoglobin
|
Baseline, 9 and 21 months
|
|
Fast blood glucose
Time Frame: Baseline, 9 and 21 months
|
mg/dL
|
Baseline, 9 and 21 months
|
|
Total Cholesterol
Time Frame: Baseline, 9 and 21 months
|
mg/dL
|
Baseline, 9 and 21 months
|
|
Body Fat Mass
Time Frame: Baseline, 9 and 21 months
|
Bioelectrical impedance analysis
|
Baseline, 9 and 21 months
|
|
Body Lean Mass
Time Frame: Baseline, 9 and 21 months
|
Bioelectrical impedance analysis
|
Baseline, 9 and 21 months
|
|
Quality of Sleep
Time Frame: Baseline, 9 and 21 months
|
Pittsburgh Sleep Quality Index
|
Baseline, 9 and 21 months
|
|
Symptoms of Anxiety and Depression
Time Frame: Baseline, 9 and 21 months
|
Hospital Anxiety and Depression Scale
|
Baseline, 9 and 21 months
|
|
Chronic Pain
Time Frame: Baseline, 9 and 21 months
|
Brief Pain Inventory Questionnaire
|
Baseline, 9 and 21 months
|
|
Diabetes-Dependent Quality of Life
Time Frame: Baseline, 9 and 21 months
|
Audit of Diabetes-Dependent Quality of Life Questionnaire
|
Baseline, 9 and 21 months
|
|
Habitual Physical Activity
Time Frame: Baseline, 9 and 21 months
|
International Physical Activity Questionnaire
|
Baseline, 9 and 21 months
|
|
Waist Circumference
Time Frame: Baseline, 9 and 21 months
|
cm
|
Baseline, 9 and 21 months
|
|
Falls Risk
Time Frame: Baseline, 9 and 21 months
|
Timed Up and Go Test
|
Baseline, 9 and 21 months
|
|
Sitting-Time
Time Frame: Baseline, 9 and 21 months
|
Hours per day
|
Baseline, 9 and 21 months
|
|
Energy Expenditure
Time Frame: Baseline, 9 and 21 months
|
kcal/kg/min
|
Baseline, 9 and 21 months
|
|
Body Mass Index
Time Frame: Baseline, 9 and 21 months
|
kg/m2
|
Baseline, 9 and 21 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Romeu Mendes, MD PhD, University of Trás-os-Montes e Alto Douro
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Matos M, Mendes R, Silva AB, Sousa N. Physical activity and exercise on diabetic foot related outcomes: A systematic review. Diabetes Res Clin Pract. 2018 May;139:81-90. doi: 10.1016/j.diabres.2018.02.020. Epub 2018 Feb 23.
- Vasconcelos C, Almeida A, Cabral M, Ramos E, Mendes R. The Impact of a Community-Based Food Education Program on Nutrition-Related Knowledge in Middle-Aged and Older Patients with Type 2 Diabetes: Results of a Pilot Randomized Controlled Trial. Int J Environ Res Public Health. 2019 Jul 6;16(13):2403. doi: 10.3390/ijerph16132403.
- Vasconcelos C, Almeida A, Sa C, Viana J, Cabral M, Ramos E, Mendes R. Nutrition-related knowledge and its determinants in middle-aged and older patients with type 2 diabetes. Prim Care Diabetes. 2020 Apr;14(2):119-125. doi: 10.1016/j.pcd.2019.06.007. Epub 2019 Jul 24.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 1, 2015
Primary Completion (Actual)
June 1, 2018
Study Completion (Actual)
December 1, 2018
Study Registration Dates
First Submitted
October 11, 2015
First Submitted That Met QC Criteria
December 13, 2015
First Posted (Estimate)
December 16, 2015
Study Record Updates
Last Update Posted (Actual)
August 20, 2019
Last Update Submitted That Met QC Criteria
August 17, 2019
Last Verified
August 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- UTras
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type 2 Diabetes Mellitus
-
University of North Carolina, Chapel HillAmerican Heart AssociationRecruitingType 2 Diabetes | Nutrition | Diabetes Type 2 | T2DM (Type 2 Diabetes Mellitus) | Diabetes Mellitis | T2DM | Diabetes EducationUnited States
-
Instituto Nacional de Ciencias Medicas y Nutricion...Active, not recruiting
-
Endogenex, Inc.Not yet recruitingDiabetes Mellitus, Type 2 | Diabetes | Type 2 Diabetes Mellitus | Type 2 Diabetes | Type2diabetes
-
University of SalamancaUniversity of Salamanca; Instituto Piaget; Escola Superior de Tecnologia da Saúde...Enrolling by invitationType 2 Diabetes Mellitus | Aging | Hyperglycemia Due to Type 2 Diabetes MellitusPortugal
-
Endogenex, Inc.Not yet recruitingDiabetes Mellitus, Type 2 | Diabetes | Type 2 Diabetes | Type 2 Diabetes Mellitus (T2DM) | Type2Diabetes
-
University of Colorado, DenverMassachusetts General Hospital; Ann & Robert H Lurie Children's Hospital of... and other collaboratorsRecruitingDiabetes Mellitus | Diabetes | Type 2 Diabetes | Diabetes Mellitus Type 2 | Diabetes Mellitus, Type I | Diabetes Mellitus Type II | Diabetes Mellitus, Insulin-Dependent | Diabetes, Autoimmune | Type 1 Diabetes (T1D) | Diabetes Type 2 on Insulin | Diabetes, Type IIUnited States
-
Kaiser PermanenteThe Permanente Medical GroupEnrolling by invitationType 2 Diabetes | Type 2 Diabetes Mellitus (T2DM) | Type 2 Diabetes (T2D)United States
-
Medical University of GrazCompletedType 2 Diabetes | Type 2 Diabetes Mellitus (T2DM) | Type 2 Diabetes, Insulin RequiringAustria
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Canterbury Christ Church UniversityBarts & The London NHS Trust; Betsi Cadwaladr University Health BoardRecruitingType 1 Diabetes Mellitus | Type 2 Diabetes Mellitus (T2DM)United Kingdom
Clinical Trials on Exercise
-
National Institute of Neurological Disorders and...TerminatedTraumatic Brain InjuryUnited States
-
University of Texas, El PasoRecruitingKnee Osteoarthritis | Knee Pain Chronic | Central Pain SyndromeUnited States
-
Aksaray University Training and Research HospitalCompletedExercise Training | Lactate Blood Increase | Cognitive Functions | BDNFTurkey (Türkiye)
-
University of Alabama at BirminghamCompletedCystic FibrosisUnited States
-
University of LisbonFundação para a Ciência e a TecnologiaActive, not recruiting
-
University of Missouri-ColumbiaCompleted
-
University of AlcalaCompletedMyofascial Pain | Myofascial Pain Syndrome | Post Needling Soreness | Myofascial Trigger Point PainSpain
-
Toronto Rehabilitation InstituteCompletedAcute Myeloid LeukemiaCanada
-
University College CorkRecruitingDepressive Disorder, MajorIreland
-
Sahmyook UniversityRecruitingChronic Nonspecific Neck PainKorea, Republic of